Side Area Image
Novita Healthcare Limited (ASX:NHL) is an Australian Medical Technology Company listed on the Australian Securities Exchange. Novita's core focus is the development of TALI Health and the TALI Technology.
1300 082 013
info@novitahealthcare.com.au

ASX Announcements

HomeInvestors CentreASX Announcements

New Newly Sale and Healthcarelink Investment Completion
New Notice of Annual General Meeting
New Change in Substantial Holding
Change of Director's Interest Notice
Appendix 3B
Date of AGM
Appendix 4C - quarterly
Company Presentation
Trading Halt
Board Restructure
COMPANY UPDATE & APPENDIX 4C QUARTER ENDED 31 MARCH 2018
Appendix 4C Quarterly
Change in Substantial Holding DAK
Novita Healthcare Company Presentation 2017
Novita Healthcare Awarded A $1.2M Grant
Appendix 3B - Directors Options
Change of Director's Interest Notices - 3 Directors
Results of Meeting AGM
Chairman's Address to Shareholders
Appendix 4C September 2017 Quarterly
Appendix 3B
Notice of Annual General Meeting Proxy Form
Becoming a Substantial Holder
Initial Director's Interest Notice
Director Appointment
Change of Director's Interest Notice - Mr Harcourt
Novita Healthcare Limited Annual Report 2017 v2
Changed Date of 2017 AGM
Appendix 4E Including Final Financial Report 2017
Appendix 4G
Appendix 3B & Cleansing Notice
Appendix 3Y for Three Directors
Rights Issue Success and Shortfall Notification
Appendix 3B and Cleansing Notice
Results of Meeting EGM
Results of EGM
Company Update & Appendix 4C Quarterly
Newly Acquisition Completed
Notice of Extraordinary General Meeting Proxy Form
Appendix 3B
Letter to Shareholders re Rights Issue
Non-Renounceable Issue Offer Document
Acquisition and Capital Raising
Capital Raising Presentation
Non-Renounceable Issue Cleaning Notice & Appendix 3B
Company Update
Change of Address
Half Yearly Report & Accounts
Company Update & Appendix 4C
Results of AGM
Unmarketable Parcel Share Sale Facility Closed
Share Sale Facility
Change of Company Name
Chairmans Presentation to Shareholders
Final Directors Interest Notice - Mr Tan Retires
Notice of Annual General Meeting
Corporate Governance Statement & Appendix 4G
Notice of Annual General Meeting Proxy Form
Appendix 4C Quarterly
Annual Report to Shareholders 2016
Unmarketable Parcel Share Sale Facility & Form
AVX_2016-10-21_Change-of-Registry
AVX_2016-10-10_Company-Secretary-Appointment-Resignation
AVX_2016-09-02_Change-of-Directors-Interest-Notice_Iain-Kirkwood
AVX_2016-09-02_Change-of-Directors-Interest-Notice_Jefferson-Harcourt
AVX_2016-09-01_Initial-Directors-Interest-Notice_Mark-Simari
AVX_2016-09-01_Non-Executive-Director-Appointment_Mark-Simari
AVX_2016-08-30_Full-Year-Statutory-Accounts
AVX_2016-08-30_Preliminary-Final-Report
AVX_2016-08-29_Rights-Issue-Allotment-Appendix-3B-Cleansing-Notice
AVX_2016-08-26_Rights-Issue-Closed-Avexa-Raises-2.2-Million
AVX_2016-08-09_Rights-Issue-Dispatch-of-Offer-Booklet
AVX_2016-08-02_Final-Directors-Interest-Notice
AVX_2016-08-02_Rights-Issue-Letter-to-Shareholders
AVX_2016-07-29_Cleansing-Notice-and-Appendix-3B
AVX_2016-07-29_Rights-Issue-Offer-Document
AVX_2016-07-29_Appendix-4C-Quarterly
AVX_2016-07-27_Capital-Raising-Presentation
AVX_2016-07-27_Rights-Issue-Announcement
AVX_2016-07-25_Trading-Halt
AVX_2016-07-19_Final-Directors-Interest-Notice_Bruce-Hewett
AVX_2016-07-12_Director-Resignation_Bruce-Hewett
AVX_2016-07-08_Change-of-Directors-Interest-Notice
AVX_2016-06-28_Change-of-Directors-Interest-Notice_Iain-Kirkwood
AVX_2016-06-16_Company-Update
AVX_2016-06-09_Interview-with-Open-Briefing
AVX_2016-06-06_Change-of-Directors-Interest-Notice_Benjamin-Yeo